Mathews Journal of Immunology & Allergy (MJIA; ISSN 2575-9523) is a scholarly journal of international repute that publishes peer-reviewed research on key topics, such as the immune system, innate and adaptive immunity, antibody response, T and B lymphocytes, anaphylaxis, primary immune deficiencies, infectious disease, occupational and environmental allergy, allergic rhinitis, food allergy, angioedema, asthma, atopic dermatitis, antihistamines, and monoclonal antibody generation.
MJIA publishes high-impact clinical and translational research manuscripts aimed at immunologists, allergists, and medical professionals and researchers interested in studying clinical immunology and allergic diseases and associated mechanisms. The journal publishes clinical trials and mechanistic studies investigating novel therapies and providing insights into the underlying mechanisms, with special focus on discoveries that will enrich our understanding of immune and allergy related diseases that will ultimately improve the diagnosis and management of patients affected by these conditions.
MJIA aims to serve as an international forum for showcasing the work of authoritative medical professionals, researchers, and scientists.
Why publish with us?
High Visibility: MJIA follows an open access policy that allows published articles to reach across the globe.
Promotion in Social Media: MJIA promotes articles by providing alerts and regular email updates to subscribers.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.
We welcome all types of articles related to Immunology & Allergy. Please follow the Author Guidelines. For submission assistance contact: [email protected].
If you are not sure whether your work is suitable for this journal, please email us at [email protected] or call us at +1-606-405–6566.
Published : 30th June 2021
Authors : Dritan Ulqinaku1, Gentian Vyshka2*
Citation : Ulqinaku D, and Vyshka G. (2021). Aftershock of a Vaccination Gap: The Measles Epidemics in Tirana, 2018. Mathews J Immunol Allergy. 5(1):13.
Published : 13th March 2021
Authors : Tshimanga S1*, Fouad A1, Fakiri K1, Rada N1, Draiss G1, Edmou B2, Bouskraoui M1
Citation : Tshimanga S, Fouad A, Fakiri K, Rada N, Draiss G, Edmou B. (2021). Reticular Dysgenesis: Fiction or Reality in Morocco. Mathews J Immunol Allergy. (5)1:12.
Published : 16th February 2021
Author : Sarah El-Nakeep
Citation : Sarah El-Nakeep. (2021). Literature Review of the Published Human Clinical Trials: On COVID-19 Vaccines. Mathews J Immunol Allergy. (5)1:11
Published : 21st December 2020
Authors : Farouk S. Nas1, Muhammad Ali2*, Lurwan Mu’azu3, Muhammad S. Abdallah4
Citation : Nas FS, et al. (2020). Seroprevalence of Dengue Fever among Febrile Patients Attending Kura General Hospital Kano, Nigeria?. Mathews J Immunol Allergy. (4)1:10.
Published : 30th September 2019
Authors : Viviane Martha Santos de Morais1* and Maria Rosângela Cunha Duarte Coelho1,2
Citation : de Morais VMS. (2019). An Opinion about the Importance of MBL in HIV/HHV-8 Coinfection. Mathews J Immunol Allergy. 3(2): 9.
Published : 16th September 2019
Authors : John G Prichard1*, Delilah D Coconubo2, Melanie Gero3, Behzad Noorbehesht4, Michelle Azimov5
Citation : Prichard JG. (2019). Acquired C1-Esterase Inhibitor Deficiency Associated with Burkitt Lymphoma. Mathews J Immunol Allergy 3(1): 8.